© 1996 Oxford University Press
research-article |
Exposure to dimethylarsinic acid, a main metabolite of inorganic arsenics, strongly promotes tumorigenesis initiated by 4-nitroquinoline 1-oxide in the lungs of mice
Department of Biochemical Toxicology, Nihon University College of Pharmacy 7-7-1 Narashinodai, Funabashi-shi, Chiba 274
2Department of Pathology, Yokoham City University School of Medicine 3-9 Fuku-ura. Kanazawa-ku, Yokohama 236
3Department of Radiobiochemistry, University of Shizuoda School of Pharmaceuticfal Sciences 52-1 Yada. Shizuoka-shi, Shizuoka 422, Japan
1To whom requests for reprins should be addressed
The effect of dimethylarsenics on the pulmonary tumorigenesis initiated by 4-nitroquinoline 1-(4NQO) in mice was examined. The exposure of mice to dimethylarsinic acid (DMAA), a major metabolite of inorganic arsenics in mammals, resulted in not only promotion but also progression of the tumorigenic process in the lungs of mice administered 4NQO. Furthermore, dimethylarsenice influenced the differentiation process in lung tumorigenesis by 4NQO. These results may pave the way for the elucidation of lung carcinogenesis caused by arsenics.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. V. Evans, S. M. Dowd, E. M. Kenyon, M. F. Hughes, and H. A. El-Masri A Physiologically based Pharmacokinetic Model for Intravenous and Ingested Dimethylarsinic Acid in Mice Toxicol. Sci., August 1, 2008; 104(2): 250 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Kenyon, L. M. Del Razo, and M. F. Hughes Tissue Distribution and Urinary Excretion of Inorganic Arsenic and Its Methylated Metabolites in Mice Following Acute Oral Administration of Arsenate Toxicol. Sci., May 1, 2005; 85(1): 468 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsuchiya, T. Tanaka-Kagawa, H. Jinno, H. Tokunaga, K. Sakimoto, M. Ando, and M. Umeda Inorganic Arsenic Compounds and Methylated Metabolites Induce Morphological Transformation in Two-Stage BALB/c 3T3 Cell Assay and Inhibit Metabolic Cooperation in V79 Cell Assay Toxicol. Sci., April 1, 2005; 84(2): 344 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, M. B. Kadiiska, Y. Liu, T. Lu, W. Qu, and M. P. Waalkes Stress-Related Gene Expression in Mice Treated with Inorganic Arsenicals Toxicol. Sci., June 1, 2001; 61(2): 314 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Stoica, E. Pentecost, and M. B. Martin Effects of Arsenite on Estrogen Receptor-{alpha} Expression and Activity in MCF-7 Breast Cancer Cells Endocrinology, October 1, 2000; 141(10): 3595 - 3602. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huff, P. Chan, and A. Nyska Is the Human Carcinogen Arsenic Carcinogenic to Laboratory Animals? Toxicol. Sci., May 1, 2000; 55(1): 17 - 23. [Full Text] [PDF] |
||||
![]() |
H. J. Clewell, P. R. Gentry, H. A. Barton, A. M. Shipp, J. W. Yager, and M. E. Andersen Requirements for a Biologically Realistic Cancer Risk Assessment for Inorganic Arsenic International Journal of Toxicology, March 1, 1999; 18(2): 131 - 147. [Abstract] [PDF] |
||||


